Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|September 27, 2019
Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperativelyMichał Jarząb, Ewa Stobiecka, Agnieszka Badora-Rybicka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 28, 2025
Strategies for premedication and G-CSF application in sacituzumab govitecan treatment of patients with triple-negative breast cancer: multicenter insightsMałgorzata Pieniążek, Anna Polakiewicz-Gilowska, Marcin Kubeczko, et al.
Frontiers in Oncology|June 24, 2024
Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysisMarcin Kubeczko, Anna Polakiewicz-Gilowska, Katarzyna Świderska, et al.
Oncology and Therapy|September 27, 2024
Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort StudyMiroslawa Püsküllüoğlu, Małgorzata Pieniążek, Manuela Las-Jankowska, et al.
Breast Cancer Research and Treatment|December 9, 2025
Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series from CEBCC-102 studyJustyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
Cancers|February 11, 2023
Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast CancerMarcin Kubeczko, Dorota Gabryś, Marzena Gawkowska, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 2, 2026
Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohortKarolina Winsko-Szczęsnowicz, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
The Oncologist|January 23, 2026
Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central EuropeMałgorzata Pieniążek, Anna Polakiewicz-Gilowska, Justyna Żubrowska, et al.
Breast (Edinburgh, Scotland)|January 21, 2026
Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort studyJustyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, et al.
Oncology Research|June 4, 2026
Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and SlovakiaRenata Pacholczak-Madej, Mirosława Püsküllüoğlu, Anna Polakiewicz-Gilowska, et al.
Pageof 2